Boos et al. [151] also showed that CRC cells in PDOs following prolonged exposure to combination of folinic acid, 5-FU and irinotecan (FOLFIRI) were less sensitive to dual pathway of anti-EGFR. The gene discussed is EGFR; the disease is colorectal carcinoma.